These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5611240)

  • 21. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 24. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 25. [Reactogenic and epidemiological effectiveness of the Leningrad-4 live measles vaccine according to observations in Sverdlovsk].
    Grinberg GD; Nedel'ko NP; Andrievskaia RA; Ioffe EI; Kuznetsova TV
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():215-21. PubMed ID: 5860941
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in circadian biorhythms of autonomic functions in children aged 3 to 6 years after anti-measles vaccination].
    Sadikov OIu; Lakotkina EA; Shipitsyna LM
    Fiziol Cheloveka; 1987; 13(6):998-1005. PubMed ID: 3443250
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the vaccination against measles with a use of a live vaccine in Rowno and in Rowno district].
    Levchenko IF
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():411-5. PubMed ID: 5860961
    [No Abstract]   [Full Text] [Related]  

  • 29. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Data for the evaluation of the epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-4 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Malafeeva LK; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():309-20. PubMed ID: 5893106
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles vaccine efficacy in Masvingo district, Zimbabwe.
    Mudzamiri WS; Peterson DE; Marufu T; Biellik RJ; L'Herminez M
    Cent Afr J Med; 1996 Jul; 42(7):195-7. PubMed ID: 8936783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large measles outbreak at a German public school, 2006.
    Wichmann O; Hellenbrand W; Sagebiel D; Santibanez S; Ahlemeyer G; Vogt G; Siedler A; van Treeck U
    Pediatr Infect Dis J; 2007 Sep; 26(9):782-6. PubMed ID: 17721371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
    Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
    An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Data for the study of reactogenic and epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-16 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():321-9. PubMed ID: 5860951
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the immunologic activity of live measles vaccine AMN USSR from strain ESHCH according the material of Ukrainian SSR].
    Voroshylova MK; Chumakov MP; Syniak KM; Ralko LP; Romanenko VF; Rodin VI; Khozynskyĭ VI; Uryryn AI; Chudnaia LM; Lebedieva IR
    Pediatr Akus Ginekol; 1968 Jan; 1():24-5. PubMed ID: 5669027
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical aspects of the vaccination campaign with a dose of 500 TCD-50 of live attenuated measles vaccine in the Materno-Infantile Clinic of "La Palmilla" District, Northern Hospital District of Santiago. National Health Service. (Preliminary report)].
    Villarroel L; Oyarce P; Monreal R; Roman N; Canelo J; Palaneck K; Vildosola C
    Pediatria (Santiago); 1965; 8(2):121-6. PubMed ID: 5842687
    [No Abstract]   [Full Text] [Related]  

  • 39. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cost-effectiveness analysis on two different measles immunization strategies].
    Wu H; Wang K; Zhang X; Jin S; Feng Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):121-3. PubMed ID: 11860771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.